Catapano A.L.

Graham I.

De Backer G.

Wiklund O.

Chapman M.J.

Drexel H.

Hoes A.W.

Jennings C.S.

Landmesser U.

Pedersen T.R.

Reiner Z.

Riccardi G.

Taskinen M.R.

Tokgozoglu L.

Verschuren W.M.M.

Vlachopoulos C.

Wood D.A.

Zamorano J.L.

Cooney M.T.

ESC Scientific Document Group ESC/EAS Guidelines for the management of dyslipidaemias. Eur. Heart J. 37 ( ) : 2999-3058 View in Article Scopus (1264)

PubMed

Crossref

Google Scholar

Ference B.A.

Ginsberg H.N.

Graham I.

Ray K.K.

Packard C.J.

Bruckert E.

Hegele R.A.

Krauss R.M.

Raal F.J.

Schunkert H.

Watts G.F.

Boren J.

Fazio S.

Horton J.D.

Masana L.

Nicholls S.J.

Nordestgaard B.G.

van de Sluis B.

Taskinen M.R.

Tokgozoglu L.

Landmesser U.

Laufs U.

Wiklund O.

Stock J.K.

Chapman M.J.

Catapano A.L. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 38 : 2459-2472 View in Article Scopus (471)

PubMed

Crossref

Google Scholar

Townsend N.

Nichols M.

Scarborough P.

Rayner M. Cardiovascular disease in Europe--epidemiological update 2015. Eur. Heart J. 36 : 2696-2705 View in Article PubMed

Crossref

Google Scholar

Cooney M.T.

Dudina A.

Whincup P.

Capewell S.

Menotti A.

Jousilahti P.

Njolstad I.

Oganov R.

Thomsen T.

Tverdal A.

Wedel H.

Wilhelmsen L.

Graham I.

Investigators S.C.O.R.E. Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur. J. Cardiovasc. Prev. Rehabil. 16 : 541-549 View in Article Scopus (71)

PubMed

Crossref

Google Scholar

World Health Organization Global status report on noncommunicable diseases 2014. World Health Organization. ( ) https://www.who.int/nmh/publications/ncd-status-report-2014/en/ Date accessed: July 17, 2019 View in Article Google Scholar

Cooney M.T.

Dudina A.L.

Graham I.M. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J. Am. Coll. Cardiol. 54 : 1209-1227 View in Article Scopus (259)

PubMed

Crossref

Google Scholar

Hajifathalian K.

Ueda P.

Lu Y.

Woodward M.

Ahmadvand A.

Aguilar-Salinas C.A.

Azizi F.

Cifkova R.

Di Cesare M.

Eriksen L.

Farzadfar F.

Ikeda N.

Khalili D.

Khang Y.H.

Lanska V.

Leon-Munoz L.

Magliano D.

Msyamboza K.P.

Oh K.

Rodriguez-Artalejo F.

Rojas-Martinez R.

Shaw J.E.

Stevens G.A.

Tolstrup J.

Zhou B.

Salomon J.A.

Ezzati M.

Danaei G. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 3 : 339-355 View in Article Scopus (84)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Cooney M.T.

Dudina A.

D'Agostino R.

Graham I.M. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?. Circulation. 122 : 300-310 View in Article Scopus (154)

PubMed

Crossref

Google Scholar

Perk J.

De Backer G.

Gohlke H.

Graham I.

Reiner Z.

Verschuren M.

Albus C.

Benlian P.

Boysen G.

Cifkova R.

Deaton C.

Ebrahim S.

Fisher M.

Germano G.

Hobbs R.

Hoes A.

Karadeniz S.

Mezzani A.

Prescott E.

Ryden L.

Scherer M.

Syvanne M.

Scholte op Reimer W.J.

Vrints C.

Wood D.

Zamorano J.L.

Zannad F. European association for cardiovascular prevention & rehabilitation; ESC Committee for practice guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth Joint task force of the European society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 33 : 1635-1701 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Piepoli M.F.

Hoes A.W.

Agewall S.

Albus C.

Brotons C.

Catapano A.L.

Cooney M.T.

Corra U.

Cosyns B.

Deaton C.

Graham I.

Hall M.S.

Hobbs F.D.

Lochen M.L.

Lollgen H.

Marques-Vidal P.

Perk J.

Prescott E.

Redon J.

Richter D.J.

Sattar N.

Smulders Y.

Tiberi M.

van der Worp H.B.

van Dis I.

Verschuren W.M.

Authors/Task Force M. European guidelines on cardiovascular disease prevention in clinical practice: the sixth Joint task force of the European society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR). Eur. Heart J. 37 ( ) : 2315-2381 View in Article PubMed

Crossref

Google Scholar

Cooney M.T.

Selmer R.

Lindman A.

Tverdal A.

Menotti A.

Thomsen T.

DeBacker G.

De Bacquer D.

Tell G.S.

Njolstad I.

Graham I.M.

SCORE and CONOR investigators Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 23 : 1093-1103 View in Article Scopus (62)

PubMed

Crossref

Google Scholar

Kavousi M.

Elias-Smale S.

Rutten J.H.

Leening M.J.

Vliegenthart R.

Verwoert G.C.

Krestin G.P.

Oudkerk M.

de Maat M.P.

Leebeek F.W.

Mattace-Raso F.U.

Lindemans J.

Hofman A.

Steyerberg E.W.

van der Lugt A.

van den Meiracker A.H.

Witteman J.C. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann. Intern. Med. 156 : 438-444 View in Article PubMed

Crossref

Google Scholar

Vlachopoulos C.

Xaplanteris P.

Aboyans V.

Brodmann M.

Cifkova R.

Cosentino F.

De Carlo M.

Gallino A.

Landmesser U.

Laurent S.

Lekakis J.

Mikhailidis D.P.

Naka K.K.

Protogerou A.D.

Rizzoni D.

Schmidt-Trucksass A.

Van Bortel L.

Weber T.

Yamashina A.

Zimlichman R.

Boutouyrie P.

Cockcroft J.

O'Rourke M.

Park J.B.

Schillaci G.

Sillesen H.

Townsend R.R. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 241 : 507-532 View in Article PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Yeboah J.

McClelland R.L.

Polonsky T.S.

Burke G.L.

Sibley C.T.

O'Leary D.

Carr J.J.

Goff D.C.

Greenland P.

Herrington D.M. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. J. Am. Med. Assoc. 308 : 788-795 View in Article Scopus (553)

PubMed

Crossref

Google Scholar

Madsen C.M.

Varbo A.

Nordestgaard B.G. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur. Heart J. 38 : 2478-2486 View in Article Scopus (101)

PubMed

Crossref

Google Scholar

Mortensen M.B.

Falk E.

Li D.

Nasir K.

Blaha M.J.

Sandfort V.

Rodriguez C.J.

Ouyang P.

Budoff M. Statin trials, cardiovascular events, and coronary artery calcification: implications for a trial-based approach to statin therapy in MESA. JACC Cardiovasc Imaging. 11 : 221-230 View in Article Scopus (23)

PubMed

Crossref

Google Scholar

Lin J.S.

Evans C.V.

Johnson E.

Redmond N.

Coppola E.L.

Smith N. Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US Preventive Services Task Force. J. Am. Med. Assoc. 320 : 281-297 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Baber U.

Mehran R.

Sartori S.

Schoos M.M.

Sillesen H.

Muntendam P.

Garcia M.J.

Gregson J.

Pocock S.

Falk E.

Fuster V. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J. Am. Coll. Cardiol. 65 : 1065-1074 View in Article Scopus (157)

PubMed

Crossref

Google Scholar

McDermott M.M.

Kramer C.M.

Tian L.

Carr J.

Guralnik J.M.

Polonsky T.

Carroll T.

Kibbe M.

Criqui M.H.

Ferrucci L.

Zhao L.

Hippe D.S.

Wilkins J.

Xu D.

Liao Y.

McCarthy W.

Yuan C. Plaque composition in the proximal superficial femoral artery and peripheral artery disease events. JACC Cardiovasc Imaging. 10 : 1003-1012 View in Article Scopus (15)

PubMed

Crossref

Google Scholar

Sillesen H.

Sartori S.

Sandholt B.

Baber U.

Mehran R.

Fuster V. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 19 : 1042-1050 View in Article PubMed

Crossref

Google Scholar

Perrone-Filardi P.

Achenbach S.

Mohlenkamp S.

Reiner Z.

Sambuceti G.

Schuijf J.D.

Van der Wall E.

Kaufmann P.A.

Knuuti J.

Schroeder S.

Zellweger M.J. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur. Heart J. 32 ( ) : 1986-1993 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Den Ruijter H.M.

Peters S.A.

Anderson T.J.

Britton A.R.

Dekker J.M.

Eijkemans M.J.

Engstrom G.

Evans G.W.

de Graaf J.

Grobbee D.E.

Hedblad B.

Hofman A.

Holewijn S.

Ikeda A.

Kavousi M.

Kitagawa K.

Kitamura A.

Koffijberg H.

Lonn E.M.

Lorenz M.W.

Mathiesen E.B.

Nijpels G.

Okazaki S.

O'Leary D.H.

Polak J.F.

Price J.F.

Robertson C.

Rembold C.M.

Rosvall M.

Rundek T.

Salonen J.T.

Sitzer M.

Stehouwer C.D.

Witteman J.C.

Moons K.G.

Bots M.L. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. J. Am. Med. Assoc. 308 : 796-803 View in Article Scopus (367)

PubMed

Crossref

Google Scholar

Lorenz M.W.

Schaefer C.

Steinmetz H.

Sitzer M. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS). Eur. Heart J. 31 : 2041-2048 View in Article Scopus (135)

PubMed

Crossref

Google Scholar

Hong J.C.

Blankstein R.

Shaw L.J.

Padula W.V.

Arrieta A.

Fialkow J.A.

Blumenthal R.S.

Blaha M.J.

Krumholz H.M.

Nasir K. Implications of coronary artery calcium testing for treatment decisions among statin candidates according to the ACC/AHA cholesterol management guidelines: a cost-effectiveness analysis. JACC Cardiovasc Imaging. 10 : 938-952 View in Article Scopus (23)

PubMed

Crossref

Google Scholar

Cho I.

Al'Aref S.J.

Berger A.B.O.H.

Gransar H.

Valenti V.

Lin F.Y.

Achenbach S.

Berman D.S.

Budoff M.J.

Callister T.Q.

Al-Mallah M.H.

Cademartiri F.

Chinnaiyan K.

Chow B.J.W.

DeLago A.

Villines T.C.

Hadamitzky M.

Hausleiter J.

Leipsic J.

Shaw L.J.

Kaufmann P.A.

Feuchtner G.

Kim Y.J.

Maffei E.

Raff G.

Pontone G.

Andreini D.

Marques H.

Rubinshtein R.

Chang H.J.

Min J.K. Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study. Eur. Heart J. 39 : 934-941 View in Article Scopus (25)

PubMed

Crossref

Google Scholar

Kavousi M.

Desai C.S.

Ayers C.

Blumenthal R.S.

Budoff M.J.

Mahabadi A.A.

Ikram M.A.

van der Lugt A.

Hofman A.

Erbel R.

Khera A.

Geisel M.H.

Jockel K.H.

Lehmann N.

Hoffmann U.

O'Donnell C.J.

Massaro J.M.

Liu K.

Mohlenkamp S.

Ning H.

Franco O.H.

Greenland P. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. J. Am. Med. Assoc. 316 : 2126-2134 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Boekholdt S.M.

Hovingh G.K.

Mora S.

Arsenault B.J.

Amarenco P.

Pedersen T.R.

LaRosa J.C.

Waters D.D.

DeMicco D.A.

Simes R.J.

Keech A.C.

Colquhoun D.

Hitman G.A.

Betteridge D.J.

Clearfield M.B.

Downs J.R.

Colhoun H.M.

Gotto Jr., A.M.

Ridker P.M.

Grundy S.M.

Kastelein J.J. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J. Am. Coll. Cardiol. 64 : 485-494 View in Article Scopus (313)

PubMed

Crossref

Google Scholar

Brugts J.J.

Yetgin T.

Hoeks S.E.

Gotto A.M.

Shepherd J.

Westendorp R.G.

de Craen A.J.

Knopp R.H.

Nakamura H.

Ridker P.

van Domburg R.

Deckers J.W. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ. 338 : b2376 View in Article Scopus (579)

PubMed

Crossref

Google Scholar

Cannon C.P.

Blazing M.A.

Giugliano R.P.

McCagg A.

White J.A.

Theroux P.

Darius H.

Lewis B.S.

Ophuis T.O.

Jukema J.W.

De Ferrari G.M.

Ruzyllo W.

De Lucca P.

Im K.

Bohula E.A.

Reist C.

Wiviott S.D.

Tershakovec A.M.

Musliner T.A.

Braunwald E.

Califf R.M.

IMPROVE-IT Investigators Ezetimibe added to statin therapy after acute coronary syndromes. N. Engl. J. Med. 372 : 2387-2397 View in Article Scopus (1803)

PubMed

Crossref

Google Scholar

Mills E.J.

Rachlis B.

Wu P.

Devereaux P.J.

Arora P.

Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J. Am. Coll. Cardiol. 52 : 1769-1781 View in Article Scopus (325)

PubMed

Crossref

Google Scholar

Pedersen T.R.

Faergeman O.

Kastelein J.J.

Olsson A.G.

Tikkanen M.J.

Holme I.

Larsen M.L.

Bendiksen F.S.

Lindahl C.

Szarek M.

Tsai J. Incremental Decrease in End Points through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. J. Am. Med. Assoc. 294 : 2437-2445 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Stone N.J.

Robinson J.G.

Lichtenstein A.H.

Bairey Merz C.N.

Blum C.B.

Eckel R.H.

Goldberg A.C.

Gordon D.

Levy D.

Lloyd-Jones D.M.

McBride P.

Schwartz J.S.

Shero S.T.

Smith Jr., S.C.

Watson K.

Wilson P.W.

Eddleman K.M.

Jarrett N.M.

LaBresh K.

Nevo L.

Wnek J.

Anderson J.L.

Halperin J.L.

Albert N.M.

Bozkurt B.

Brindis R.G.

Curtis L.H.

DeMets D.

Hochman J.S.

Kovacs R.J.

Ohman E.M.

Pressler S.J.

Sellke F.W.

Shen W.K.

Smith Jr., S.C.

Tomaselli G.F.

American College of Cardiology/American Heart Association Task Force on Practice Guidelines ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 129 ( ) : S1-S45 View in Article Scopus (2507)

PubMed

Crossref

Google Scholar

Vallejo-Vaz A.J.

Robertson M.

Catapano A.L.

Watts G.F.

Kastelein J.J.

Packard C.J.

Ford I.

Ray K.K. Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 136 : 1878-1891 View in Article Scopus (52)

PubMed

Crossref

Google Scholar

Boren J.

Williams K.J. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr. Opin. Lipidol. 27 : 473-483 View in Article Scopus (91)

PubMed

Crossref

Google Scholar

Emerging Risk Factors Collaboration

Di Angelantonio E.

Gao P.

Pennells L.

Kaptoge S.

Caslake M.

Thompson A.

Butterworth A.S.

Sarwar N.

Wormser D.

Saleheen D.

Ballantyne C.M.

Psaty B.M.

Sundstrom J.

Ridker P.M.

Nagel D.

Gillum R.F.

Ford I.

Ducimetiere P.

Kiechl S.

Koenig W.

Dullaart R.P.

Assmann G.

D'Agostino Sr., R.B.

Dagenais G.R.

Cooper J.A.

Kromhout D.

Onat A.

Tipping R.W.

Gomez-de-la-Camara A.

Rosengren A.

Sutherland S.E.

Gallacher J.

Fowkes F.G.

Casiglia E.

Hofman A.

Salomaa V.

Barrett-Connor E.

Clarke R.

Brunner E.

Jukema J.W.

Simons L.A.

Sandhu M.

Wareham N.J.

Khaw K.T.

Kauhanen J.

Salonen JT.

Howard W.J.

Nordestgaard B.G.

Wood A.M.

Thompson S.G.

Boekholdt S.M.

Sattar N.

Packard C.

Gudnason V.

Danesh J. Lipid-related markers and cardiovascular disease prediction. J. Am. Med. Assoc. 307 : 2499-2506 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Willer C.J.

Schmidt E.M.

Sengupta S.

Peloso G.M.

Gustafsson S.

Kanoni S.

Ganna A.

Chen J.

Buchkovich M.L.

Mora S.

Beckmann J.S.

Bragg-Gresham J.L.

Chang H.Y.

Demirkan A.

Den Hertog H.M.

Do R.

Donnelly L.A.

Ehret G.B.

Esko T.

Feitosa M.F.

Ferreira T.

Fischer K.

Fontanillas P.

Fraser R.M.

Freitag D.F.

Gurdasani D.

Heikkila K.

Hypponen E.

Isaacs A.

Jackson A.U.

Johansson A.

Johnson T.

Kaakinen M.

Kettunen J.

Kleber M.E.

Li X.

Luan J.

Lyytikainen L.P.

Magnusson P.K.E.

Mangino M.

Mihailov E.

Montasser M.E.

Muller-Nurasyid M.

Nolte I.M.

O'Connell J.R.

Palmer C.D.

Perola M.

Petersen A.K.

Sanna S.

Saxena R.

Service S.K.

Shah S.

Shungin D.

Sidore C.

Song C.

Strawbridge R.J.

Surakka I.

Tanaka T.

Teslovich T.M.

Thorleifsson G.

Van den Herik E.G.

Voight B.F.

Volcik K.A.

Waite L.L.

Wong A.

Wu Y.

Zhang W.

Absher D.

Asiki G.

Barroso I.

Been L.F.

Bolton J.L.

Bonnycastle L.L.

Brambilla P.

Burnett M.S.

Cesana G.

Dimitriou M.

Doney A.S.F.

Doring A.

Elliott P.

Epstein S.E.

Ingi Eyjolfsson G.

Gigante B.

Goodarzi M.O.

Grallert H.

Gravito M.L.

Groves C.J.

Hallmans G.

Hartikainen A.L.

Hayward C.

Hernandez D.

Hicks A.A.

Holm H.

Hung Y.J.

Illig T.

Jones M.R.

Kaleebu P.

Kastelein J.J.P.

Khaw K.T.

Kim E.

Klopp N.

Komulainen P.

Kumari M.

Langenberg C.

Lehtimaki T.

Lin S.Y.

Lindstrom J.

Loos R.J.F.

Mach F.

McArdle W.L.

Meisinger C.

Mitchell B.D.

Muller G.

Nagaraja R.

Narisu N.

Nieminen T.V.M.

Nsubuga R.N.

Olafsson I.

Ong K.K.

Palotie A.

Papamarkou T.

Pomilla C.

Pouta A.

Rader D.J.

Reilly M.P.

Ridker P.M.

Rivadeneira F.

Rudan I.

Ruokonen A.

Samani N.

Scharnagl H.

Seeley J.

Silander K.

Stancakova A.

Stirrups K.

Swift A.J.

Tiret L.

Uitterlinden A.G.

van Pelt L.J.

Vedantam S.

Wainwright N.

Wijmenga C.

Wild S.H.

Willemsen G.

Wilsgaard T.

Wilson J.F.

Young E.H.

Zhao J.H.

Adair L.S.

Arveiler D.

Assimes T.L.

Bandinelli S.

Bennett F.

Bochud M.

Boehm B.O.

Boomsma D.I.

Borecki I.B.

Bornstein S.R.

Bovet P.

Burnier M.

Campbell H.

Chakravarti A.

Chambers J.C.

Chen Y.I.

Collins F.S.

Cooper R.S.

Danesh J.

Dedoussis G.

de Faire U.

Feranil A.B.

Ferrieres J.

Ferrucci L.

Freimer N.B.

Gieger C.

Groop L.C.

Gudnason V.

Gyllensten U.

Hamsten A.

Harris T.B.

Hingorani A.

Hirschhorn J.N.

Hofman A.

Hovingh G.K.

Hsiung C.A.

Humphries S.E.

Hunt S.C.

Hveem K.

Iribarren C.

Jarvelin M.R.

Jula A.

Kahonen M.

Kaprio J.

Kesaniemi A.

Kivimaki M.

Kooner J.S.

Koudstaal P.J.

Krauss R.M.

Kuh D.

Kuusisto J.

Kyvik K.O.

Laakso M.

Lakka T.A.

Lind L.

Lindgren C.M.

Martin N.G.

Marz W.

McCarthy M.I.

McKenzie C.A.

Meneton P.

Metspalu A.

Moilanen L.

Morris A.D.

Munroe P.B.

Njolstad I.

Pedersen N.L.

Power C.

Pramstaller P.P.

Price J.F.

Psaty B.M.

Quertermous T.

Rauramaa R.

Saleheen D.

Salomaa V.

Sanghera D.K.

Saramies J.

Schwarz P.E.H.

Sheu W.H.

Shuldiner A.R.

Siegbahn A.

Spector T.D.

Stefansson K.

Strachan D.P.

Tayo B.O.

Tremoli E.

Tuomilehto J.

Uusitupa M.

van Duijn C.M.

Vollenweider P.

Wallentin L.

Wareham N.J.

Whitfield J.B.

Wolffenbuttel B.H.R.

Ordovas J.M.

Boerwinkle E.

Palmer C.N.A.

Thorsteinsdottir U.

Chasman D.I.

Rotter J.I.

Franks P.W.

Ripatti S.

Cupples L.A.

Sandhu M.S.

Rich S.S.

Boehnke M.

Deloukas P.

Kathiresan S.

Mohlke K.L.

Ingelsson E.

Abecasis G.R. Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45 : 1274-1283 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Nikpay M.

Goel A.

Won H.H.

Hall L.M.

Willenborg C.

Kanoni S.

Saleheen D.

Kyriakou T.

Nelson C.P.

Hopewell J.C.

Webb T.R.

Zeng L.

Dehghan A.

Alver M.

Armasu S.M.

Auro K.

Bjonnes A.

Chasman D.I.

Chen S.

Ford I.

Franceschini N.

Gieger C.

Grace C.

Gustafsson S.

Huang J.

Hwang S.J.

Kim Y.K.

Kleber M.E.

Lau K.W.

Lu X.

Lu Y.

Lyytikainen L.P.

Mihailov E.

Morrison A.C.

Pervjakova N.

Qu L.

Rose L.M.

Salfati E.

Saxena R.

Scholz M.

Smith A.V.

Tikkanen E.

Uitterlinden A.

Yang X.

Zhang W.

Zhao W.

de Andrade M.

de Vries P.S.

van Zuydam N.R.

Anand S.S.

Bertram L.

Beutner F.

Dedoussis G.

Frossard P.

Gauguier D.

Goodall A.H.

Gottesman O.

Haber M.

Han B.G.

Huang J.

Jalilzadeh S.

Kessler T.

Konig I.R.

Lannfelt L.

Lieb W.

Lind L.

Lindgren C.M.

Lokki M.L.

Magnusson P.K.

Mallick N.H.

Mehra N.

Meitinger T.

Memon F.U.

Morris A.P.

Nieminen M.S.

Pedersen N.L.

Peters A.

Rallidis L.S.

Rasheed A.

Samuel M.

Shah S.H.

Sinisalo J.

Stirrups K.E.

Trompet S.

Wang L.

Zaman K.S.

Ardissino D.

Boerwinkle E.

Borecki I.B.

Bottinger E.P.

Buring J.E.

Chambers J.C.

Collins R.

Cupples L.A.

Danesh J.

Demuth I.

Elosua R.

Epstein S.E.

Esko T.

Feitosa M.F.

Franco O.H.

Franzosi M.G.

Granger C.B.

Gu D.

Gudnason V.

Hall A.S.

Hamsten A.

Harris T.B.

Hazen S.L.

Hengstenberg C.

Hofman A.

Ingelsson E.

Iribarren C.

Jukema J.W.

Karhunen P.J.

Kim B.J.

Kooner J.S.

Kullo I.J.

Lehtimaki T.

Loos R.J.F.

Melander O.

Metspalu A.

Marz W.

Palmer C.N.

Perola M.

Quertermous T.

Rader D.J.

Ridker P.M.

Ripatti S.

Roberts R.

Salomaa V.

Sanghera D.K.

Schwartz S.M.

Seedorf U.

Stewart A.F.

Stott D.J.

Thiery J.

Zalloua P.A.

O'Donnell C.J.

Reilly M.P.

Assimes T.L.

Thompson J.R.

Erdmann J.

Clarke R.

Watkins H.

Kathiresan S.

McPherson R.

Deloukas P.

Schunkert H.

Samani N.J.

Farrall M. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47 : 1121-1130 View in Article Scopus (620)

PubMed

Crossref

Google Scholar

Ference B.A.

Yoo W.

Alesh I.

Mahajan N.

Mirowska K.K.

Mewada A.

Kahn J.

Afonso L.

Williams Sr., K.A.

Flack J.M. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J. Am. Coll. Cardiol. 60 : 2631-2639 View in Article Scopus (366)

PubMed

Crossref

Google Scholar

Holmes M.V.

Asselbergs F.W.

Palmer T.M.

Drenos F.

Lanktree M.B.

Nelson C.P.

Dale C.E.

Padmanabhan S.

Finan C.

Swerdlow D.I.

Tragante V.

van Iperen E.P.

Sivapalaratnam S.

Shah S.

Elbers C.C.

Shah T.

Engmann J.

Giambartolomei C.

White J.

Zabaneh D.

Sofat R.

McLachlan S.

consortium U.

Doevendans P.A.

Balmforth A.J.

Hall A.S.

North K.E.

Almoguera B.

Hoogeveen R.C.

Cushman M.

Fornage M.

Patel S.R.

Redline S.

Siscovick D.S.

Tsai M.Y.

Karczewski K.J.

Hofker M.H.

Verschuren W.M.

Bots M.L.

van der Schouw Y.T.

Melander O.

Dominiczak A.F.

Morris R.

Ben-Shlomo Y.

Price J.

Kumari M.

Baumert J.

Peters A.

Thorand B.

Koenig W.

Gaunt T.R.

Humphries S.E.

Clarke R.

Watkins H.

Farrall M.

Wilson J.G.

Rich S.S.

de Bakker P.I.

Lange L.A.

Davey Smith G.

Reiner A.P.

Talmud P.J.

Kivimaki M.

Lawlor D.A.

Dudbridge F.

Samani N.J.

Keating B.J.

Hingorani A.D.

Casas J.P. Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36 : 539-550 View in Article Scopus (244)

PubMed

Crossref

Google Scholar

Silverman M.G.

Ference B.A.

Im K.

Wiviott S.D.

Giugliano R.P.

Grundy S.M.

Braunwald E.

Sabatine M.S. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. J. Am. Med. Assoc. 316 : 1289-1297 View in Article Scopus (331)

PubMed

Crossref

Google Scholar

Ference B.A.

Kastelein J.J.P.

Ray K.K.

Ginsberg H.N.

Chapman M.J.

Packard C.J.

Laufs U.

Oliver-Williams C.

Wood A.M.

Butterworth A.S.

Di Angelantonio E.

Danesh J.

Nicholls S.J.

Bhatt D.L.

Sabatine M.S.

Catapano A.L. Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. J. Am. Med. Assoc. 321 : 364-373 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Ference B.A.

Majeed F.

Penumetcha R.

Flack J.M.

Brook R.D. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 x 2 factorial Mendelian randomization study. J. Am. Coll. Cardiol. 65 : 1552-1561 View in Article Scopus (169)

PubMed

Crossref

Google Scholar

Ference B.A.

Robinson J.G.

Brook R.D.

Catapano A.L.

Chapman M.J.

Neff D.R.

Voros S.

Giugliano R.P.

Davey Smith G.

Fazio S.

Sabatine M.S. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N. Engl. J. Med. 375 : 2144-2153 View in Article Scopus (268)

PubMed

Crossref

Google Scholar

Lewis G.F.

Xiao C.

Hegele R.A. Hypertriglyceridemia in the genomic era: a new paradigm. Endocr. Rev. 36 : 131-147 View in Article PubMed

Crossref

Google Scholar

Frikke-Schmidt R.

Nordestgaard B.G.

Stene M.C.

Sethi A.A.

Remaley A.T.

Schnohr P.

Grande P.

Tybjaerg-Hansen A. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. J. Am. Med. Assoc. 299 : 2524-2532 View in Article Scopus (332)

PubMed

Crossref

Google Scholar

Voight B.F.

Peloso G.M.

Orho-Melander M.

Frikke-Schmidt R.

Barbalic M.

Jensen M.K.

Hindy G.

Holm H.

Ding E.L.

Johnson T.

Schunkert H.

Samani N.J.

Clarke R.

Hopewell J.C.

Thompson J.F.

Li M.

Thorleifsson G.

Newton-Cheh C.

Musunuru K.

Pirruccello J.P.

Saleheen D.

Chen L.

Stewart A.

Schillert A.

Thorsteinsdottir U.

Thorgeirsson G.

Anand S.

Engert J.C.

Morgan T.

Spertus J.

Stoll M.

Berger K.

Martinelli N.

Girelli D.

McKeown P.P.

Patterson C.C.

Epstein S.E.

Devaney J.

Burnett M.S.

Mooser V.

Ripatti S.

Surakka I.

Nieminen M.S.

Sinisalo J.

Lokki M.L.

Perola M.

Havulinna A.

de Faire U.

Gigante B.

Ingelsson E.

Zeller T.

Wild P.

de Bakker P.I.

Klungel O.H.

Maitland-van der Zee A.H.

Peters B.J.

de Boer A.

Grobbee D.E.

Kamphuisen P.W.

Deneer V.H.

Elbers C.C.

Onland-Moret N.C.

Hofker M.H.

Wijmenga C.

Verschuren W.M.

Boer J.M.

van der Schouw Y.T.

Rasheed A.

Frossard P.

Demissie S.

Willer C.

Do R.

Ordovas J.M.

Abecasis G.R.

Boehnke M.

Mohlke K.L.

Daly M.J.

Guiducci C.

Burtt N.P.

Surti A.

Gonzalez E.

Purcell S.

Gabriel S.

Marrugat J.

Peden J.

Erdmann J.

Diemert P.

Willenborg C.

Konig I.R.

Fischer M.

Hengstenberg C.

Ziegler A.

Buysschaert I.

Lambrechts D.

Van de Werf F.

Fox K.A.

El Mokhtari N.E.

Rubin D.

Schrezenmeir J.

Schreiber S.

Schafer A.

Danesh J.

Blankenberg S.

Roberts R.

McPherson R.

Watkins H.

Hall A.S.

Overvad K.

Rimm E.

Boerwinkle E.

Tybjaerg-Hansen A.

Cupples L.A.

Reilly M.P.

Melander O.

Mannucci P.M.

Ardissino D.

Siscovick D.

Elosua R.

Stefansson K.

O'Donnell C.J.

Salomaa V.

Rader D.J.

Peltonen L.

Schwartz S.M.

Altshuler D.

Kathiresan S. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet. 380 : 572-580 View in Article Scopus (1256)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Lincoff A.M.

Nicholls S.J.

Riesmeyer J.S.

Barter P.J.

Brewer H.B.

Fox K.A.A.

Gibson C.M.

Granger C.

Menon V.

Montalescot G.

Rader D.

Tall A.R.

McErlean E.

Wolski K.

Ruotolo G.

Vangerow B.

Weerakkody G.

Goodman S.G.

Conde D.

McGuire D.K.

Nicolau J.C.

Leiva-Pons J.L.

Pesant Y.

Li W.

Kandath D.

Kouz S.

Tahirkheli N.

Mason D.

Nissen S.E. ACCELERATE Investigators. Evacetrapib and cardiovascular outcomes in high-risk vascular disease. N. Engl. J. Med. 376 : 1933-1942 View in Article Scopus (62)

PubMed

Crossref

Google Scholar

HPS/TIMI/REVEAL Collaborative Group

Bowman L.

Hopewell J.C.

Chen F.

Wallendszus K.

Stevens W.

Collins R.

Wiviott S.D.

Cannon C.P.

Braunwald E.

Sammons E.

Landray M.J. Effects of anacetrapib in patients with atherosclerotic vascular disease. N. Engl. J. Med. 377 : 1217-1227 View in Article Scopus (285)

PubMed

Crossref

Google Scholar

Schwartz G.G.

Olsson A.G.

Abt M.

Ballantyne C.M.

Barter P.J.

Brumm J.

Chaitman B.R.

Holme I.M.

Kallend D.

Leiter L.A.

Leitersdorf E.

McMurray J.J.

Mundl H.

Nicholls S.J.

Shah P.K.

Tardif J.C.

Wright R.S.

Investigators dal-OUTCOMES. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med. 367 : 2089-2099 View in Article Scopus (1265)

PubMed

Crossref

Google Scholar

Aim-High Investigators

Boden W.E.

Probstfield J.L.

Anderson T.

Chaitman B.R.

Desvignes-Nickens P.

Koprowicz K.

McBride R.

Teo K.

Weintraub W. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365 : 2255-2267 View in Article Scopus (1860)

PubMed

Crossref

Google Scholar

Group H.T.C.

Landray M.J.

Haynes R.

Hopewell J.C.

Parish S.

Aung T.

Tomson J.

Wallendszus K.

Craig M.

Jiang L.

Collins R.

Armitage J. Effects of extended-release niacin with laropiprant in high-risk patients. N. Engl. J. Med. 371 : 203-212 View in Article Scopus (860)

PubMed

Crossref

Google Scholar

Andrews J.

Janssan A.

Nguyen T.

Pisaniello A.D.

Scherer D.J.

Kastelein J.J.

Merkely B.

Nissen S.E.

Ray K.

Schwartz G.G.

Worthley S.G.

Keyserling C.

Dasseux J.L.

Butters J.

Girardi J.

Miller R.

Nicholls S.J. Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. Cardiovasc. Diagn. Ther. 7 : 45-51 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Tardif J.C.

Ballantyne C.M.

Barter P.

Dasseux J.L.

Fayad Z.A.

Guertin M.C.

Kastelein J.J.

Keyserling C.

Klepp H.

Koenig W.

L'Allier P.L.

Lesperance J.

Luscher T.F.

Paolini J.F.

Tawakol A.

Waters D.D. Can HDL Infusions Significantly QUicken Atherosclerosis REgression (CHI-SQUARE) Investigators. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur. Heart J. 35 : 3277-3286 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

van der Valk F.M.

Bekkering S.

Kroon J.

Yeang C.

Van den Bossche J.

van Buul J.D.

Ravandi A.

Nederveen A.J.

Verberne H.J.

Scipione C.

Nieuwdorp M.

Joosten L.A.

Netea M.G.

Koschinsky M.L.

Witztum J.L.

Tsimikas S.

Riksen N.P.

Stroes E.S. Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans. Circulation. 134 : 611-624 View in Article Scopus (115)

PubMed

Crossref

Google Scholar

Nordestgaard B.G.

Chapman M.J.

Ray K.

Borén J.

Andreotti F.

Watts G.F.

Ginsberg H.

Amarenco P.

Catapano A.

Descamps O.S.

Fisher E.

Kovanen P.T.

Kuivenhoven J.A.

Lesnik P.

Masana L.

Reiner Z.

Taskinen M.R.

Tokgözoglu L.

Tybjærg-Hansen A. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 31 : 2844-2853 View in Article Scopus (914)

PubMed

Crossref

Google Scholar

Emerging Risk Factors Collaboration

Erqou S.

Kaptoge S.

Perry P.L.

Di Angelantonio E.

Thompson A.

White I.R.

Marcovina S.M.

Collins R.

Thompson S.G.

Danesh J. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. J. Am. Med. Assoc. 302 : 412-423 View in Article Scopus (785)

PubMed

Crossref

Google Scholar

Clarke R.

Peden J.F.

Hopewell J.C.

Kyriakou T.

Goel A.

Heath S.C.

Parish S.

Barlera S.

Franzosi M.G.

Rust S.

Bennett D.

Silveira A.

Malarstig A.

Green F.R.

Lathrop M.

Gigante B.

Leander K.

de Faire U.

Seedorf U.

Hamsten A.

Collins R.

Watkins H.

Farrall M.

PROCARDIS Consortium Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 361 : 2518-2528 View in Article Scopus (731)

PubMed

Crossref

Google Scholar

O'Donoghue M.L.

Fazio S.

Giugliano R.P.

Stroes E.S.G.

Kanevsky E.

Gouni-Berthold I.

Im K.

Lira Pineda A.

Wasserman S.M.

Ceska R.

Ezhov M.V.

Jukema J.W.

Jensen H.K.

Tokgozoglu S.L.

Mach F.

Huber K.

Sever P.S.

Keech A.C.

Pedersen T.R.

Sabatine M.S. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation. 139 : 1483-1492 View in Article Scopus (68)

PubMed

Crossref

Google Scholar

Burgess S.

Ference B.A.

Staley J.R.

Freitag D.F.

Mason A.M.

Nielsen S.F.

Willeit P.

Young R.

Surendran P.

Karthikeyan S.

Bolton T.R.

Peters J.E.

Kamstrup P.R.

Tybjaerg-Hansen A.

Benn M.

Langsted A.

Schnohr P.

Vedel-Krogh S.

Kobylecki C.J.

Ford I.

Packard C.

Trompet S.

Jukema J.W.

Sattar N.

Di Angelantonio E.

Saleheen D.

Howson J.M.M.

Nordestgaard B.G.

Butterworth A.S.

Danesh J. European Prospective Investigation into Cancer and Nutrition–Cardiovascular Disease (EPIC-CVD) Consortium. Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: a Mendelian randomization analysis. JAMA Cardiol. 3 : 619-627 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Parish S.

Hopewell J.C.

Hill M.R.

Marcovina S.

Valdes-Marquez E.

Haynes R.

Offer A.

Pedersen T.R.

Baigent C.

Collins R.

Landray M.

Armitage J.

HPS2-THRIVE Collaborative Group Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE Study. Circ Genom Precis Med. 11 e001696 View in Article Scopus (18)

PubMed

Crossref

Google Scholar

Langlois M.R.

Chapman M.J.

Cobbaert C.

Mora S.

Remaley A.T.

Ros E.

Watts G.F.

Borén J.

Baum H.

Bruckert E.

Catapano A.

Descamps O.S.

von Eckardstein A.

Kamstrup P.R.

Kolovou G.

Kronenberg F.

Langsted A.

Pulkki K.

Rifai N.

Sypniewska G.

Wiklund O.

Nordestgaard B.G. European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative. Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM. Clin. Chem. 64 : 1006-1033 View in Article Scopus (43)

PubMed

Crossref

Google Scholar

Jialal I.

Inn M.

Siegel D.

Devaraj S. Underestimation of low density lipoprotein-cholesterol with the Friedewald equation versus a direct homogenous low density lipoprotein-cholesterol assay. Lab. Med. 48 : 220-224 View in Article Scopus (2)

PubMed

Crossref

Google Scholar

Martin S.S.

Blaha M.J.

Elshazly M.B.

Brinton E.A.

Toth P.P.

McEvoy J.W.

Joshi P.H.

Kulkarni K.R.

Mize P.D.

Kwiterovich P.O.

Defilippis A.P.

Blumenthal R.S.

Jones S.R. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J. Am. Coll. Cardiol. 62 : 732-739 View in Article Scopus (156)

PubMed

Crossref

Google Scholar

Nauck M.

Warnick G.R.

Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin. Chem. 48 : 236-254 View in Article PubMed

Google Scholar

Razi F.

Forouzanfar K.

Bandarian F.

Nasli-Esfahani E. LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations. J. Diabetes Metab. Disord. 16 : 43 View in Article Scopus (2)

PubMed

Crossref

Google Scholar

Robinson J.G.

Rosenson R.S.

Farnier M.

Chaudhari U.

Sasiela W.J.

Merlet L.

Miller K.

Kastelein J.J. Safety of very low low-density lipoprotein cholesterol levels with alirocumab: pooled data from randomized trials. J. Am. Coll. Cardiol. 69 : 471-482 View in Article Scopus (84)

PubMed

Crossref

Google Scholar

Miller W.G.

Myers G.L.

Sakurabayashi I.

Bachmann L.M.

Caudill S.P.

Dziekonski A.

Edwards S.

Kimberly M.M.

Korzun W.J.

Leary E.T.

Nakajima K.

Nakamura M.

Nilsson G.

Shamburek R.D.

Vetrovec G.W.

Warnick G.R.

Remaley A.T. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin. Chem. 56 : 977-986 View in Article Scopus (156)

PubMed

Crossref

Google Scholar

Marcovina S.M.

Koschinsky M.L.

Albers J.J.

Skarlatos S. Report of the national heart, lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions. Clin. Chem. 49 : 1785-1796 View in Article Scopus (209)

PubMed

Crossref

Google Scholar

Jorgensen A.B.

Frikke-Schmidt R.

West A.S.

Grande P.

Nordestgaard B.G.

Tybjaerg-Hansen A. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur. Heart J. 34 : 1826-1833 View in Article Scopus (172)

PubMed

Crossref

Google Scholar

Kolovou G.D.

Mikhailidis D.P.

Kovar J.

Lairon D.

Nordestgaard B.G.

Ooi T.C.

Perez-Martinez P.

Bilianou H.

Anagnostopoulou K.

Panotopoulos G. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr. Vasc. Pharmacol. 9 : 258-270 View in Article Scopus (215)

PubMed

Crossref

Google Scholar

Mihas C.

Kolovou G.D.

Mikhailidis D.P.

Kovar J.

Lairon D.

Nordestgaard B.G.

Ooi T.C.

Perez-Martinez P.

Bilianou H.

Anagnostopoulou K.

Panotopoulos G. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr. Vasc. Pharmacol. 9 : 271-280 View in Article Scopus (88)

PubMed

Crossref

Google Scholar

Chapman M.J.

Ginsberg H.N.

Amarenco P.

Andreotti F.

Borén J.

Catapano A.L.

Descamps O.S.

Fisher E.

Kovanen P.T.

Kuivenhoven J.A.

Lesnik P.

Masana L.

Nordestgaard B.G.

Ray K.K.

Reiner Z.

Taskinen M.R.

Tokgözoglu L.

Tybjærg-Hansen A.

Watts G.F. European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur. Heart J. 32 : 1345-1361 View in Article Scopus (710)

PubMed

Crossref

Google Scholar

Cartier L.J.

Collins C.

Lagace M.

Douville P. Comparison of fasting and non-fasting lipid profiles in a large cohort of patients presenting at a community hospital. Clin. Biochem. 52 : 61-66 View in Article Scopus (1)

PubMed

Crossref

Google Scholar

National Clinical Guideline Centre (UK) Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. National Institute for Health and Care Excellence , London ( ) View in Article Google Scholar

Doran B.

Guo Y.

Xu J.

Weintraub H.

Mora S.

Maron D.J.

Bangalore S. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). Circulation. 130 : 546-553 View in Article Scopus (65)

PubMed

Crossref

Google Scholar

van Deventer H.E.

Miller W.G.

Myers G.L.

Sakurabayashi I.

Bachmann L.M.

Caudill S.P.

Dziekonski A.

Edwards S.

Kimberly M.M.

Korzun W.J.

Leary E.T.

Nakajima K.

Nakamura M.

Shamburek R.D.

Vetrovec G.W.

Warnick G.R.

Remaley A.T. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin. Chem. 57 : 490-501 View in Article Scopus (69)

PubMed

Crossref

Google Scholar

Willeit P.

Kiechl S.

Kronenberg F.

Witztum J.L.

Santer P.

Mayr M.

Xu Q.

Mayr A.

Willeit J.

Tsimikas S. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J. Am. Coll. Cardiol. 64 : 851-860 View in Article Scopus (135)

PubMed

Crossref

Google Scholar

European Association for Cardiovascular Prevention & Rehabilitation

Reiner Z.

Catapano A.L.

De Backer G.

Graham I.

Taskinen M.R.

Wiklund O.

Agewall S.

Alegria E.

Chapman M.J.

Durrington P.

Erdine S.

Halcox J.

Hobbs R.

Kjekshus J.

Filardi P.P.

Riccardi G.

Storey R.F.

Wood D. ESC Committee for practice guidelines Committees (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of Cardiology (ESC) and the European atherosclerosis society (EAS). Eur. Heart J. 32 : 1769-1818 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Lloyd-Jones D.M.

Morris P.B.

Ballantyne C.M.

Birtcher K.K.

Daly Jr., D.D.

DePalma S.M.

Minissian M.B.

Orringer C.E.

Smith Jr., S.C. Focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology task force on expert consensus decision pathways. J. Am. Coll. Cardiol. 70 ( ) : 1785-1822 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Navarese E.P.

Robinson J.G.

Kowalewski M.

Kolodziejczak M.

Andreotti F.

Bliden K.

Tantry U.

Kubica J.

Raggi P.

Gurbel P.A. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. J. Am. Med. Assoc. 319 : 1566-1579 View in Article Scopus (96)

PubMed

Crossref

Google Scholar

Hsia J.

MacFadyen J.G.

Monyak J.

Ridker P.M. Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). J. Am. Coll. Cardiol. 57 : 1666-1675 View in Article Scopus (171)

PubMed

Crossref

Google Scholar

Williams B.

Mancia G.

Spiering W.

Agabiti Rosei E.

Azizi M.

Burnier M.

Clement D.L.

Coca A.

de Simone G.

Dominiczak A.

Kahan T.

Mahfoud F.

Redon J.

Ruilope L.

Zanchetti A.

Kerins M.

Kjeldsen S.E.

Kreutz R.

Laurent S.

Lip G.Y.H.

McManus R.

Narkiewicz K.

Ruschitzka F.

Schmieder R.E.

Shlyakhto E.

Tsioufis C.

Aboyans V.

Desormais I.

Authors/Task Force Members ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of Cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European society of Cardiology and the European society of hypertension. J. Hypertens. 36 ( ) : 1953-2041 View in Article PubMed

Crossref

Google Scholar

Sabatine M.S.

Giugliano R.P.

Keech A.C.

Honarpour N.

Wiviott S.D.

Murphy S.A.

Kuder J.F.

Wang H.

Liu T.

Wasserman S.M.

Sever P.S.

Pedersen T.R. FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N. Engl. J. Med. 376 : 1713-1722 View in Article Scopus (1587)

PubMed

Crossref

Google Scholar

Schwartz G.G.

Steg P.G.

Szarek M.

Bhatt D.L.

Bittner V.A.

Diaz R.

Edelberg J.M.

Goodman S.G.

Hanotin C.

Harrington R.A.

Jukema J.W.

Lecorps G.

Mahaffey K.W.

Moryusef A.

Pordy R.

Quintero K.

Roe M.T.

Sasiela W.J.

Tamby J.F.

Tricoci P.

White H.D.

Zeiher A.M. ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N. Engl. J. Med. 379 : 2097-2107 View in Article Scopus (286)

PubMed

Crossref

Google Scholar

Charlton-Menys V.

Betteridge D.J.

Colhoun H.

Fuller J.

France M.

Hitman G.A.

Livingstone S.J.

Neil H.A.

Newman C.B.

Szarek M.

DeMicco D.A.

Durrington P.N. Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). Clin. Chem. 55 : 473-480 View in Article Scopus (69)

PubMed

Crossref

Google Scholar

Thanassoulis G.

Williams K.

Ye K.

Brook R.

Couture P.

Lawler P.R.

de Graaf J.

Furberg C.D.

Sniderman A. Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials. J Am Heart Assoc. 3 e000759 View in Article Scopus (63)

PubMed

Crossref

Google Scholar

Eckel R.H.

Jakicic J.M.

Ard J.D.

de Jesus J.M.

Houston Miller N.

Hubbard V.S.

Lee I.M.

Lichtenstein A.H.

Loria C.M.

Millen B.E.

Nonas C.A.

Sacks F.M.

Smith Jr., S.C.

Svetkey L.P.

Wadden T.A.

Yanovski S.Z.

Kendall K.A.

Morgan L.C.

Trisolini M.G.

Velasco G.

Wnek J.

Anderson J.L.

Halperin J.L.

Albert N.M.

Bozkurt B.

Brindis R.G.

Curtis L.H.

DeMets D.

Hochman J.S.

Kovacs R.J.

Ohman E.M.

Pressler S.J.

Sellke F.W.

Shen W.K.

Smith Jr., S.C.

Tomaselli G.F. American College of Cardiology/American heart association task force on practice guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American heart association task force on practice guidelines. Circulation. 129 : S76-S99 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Mente A.

de Koning L.

Shannon H.S.

Anand S.S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 169 : 659-669 View in Article Scopus (853)

PubMed

Crossref

Google Scholar

Chowdhury R.

Warnakula S.

Kunutsor S.

Crowe F.

Ward H.A.

Johnson L.

Franco O.H.

Butterworth A.S.

Forouhi N.G.

Thompson S.G.

Khaw K.T.

Mozaffarian D.

Danesh J.

Di Angelantonio E. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann. Intern. Med. 160 : 398-406 View in Article PubMed

Crossref

Google Scholar

Mozaffarian D.

Micha R.

Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 7 e1000252 View in Article Scopus (644)

PubMed

Crossref

Google Scholar

Chen M.

Li Y.

Sun Q.

Pan A.

Manson J.E.

Rexrode K.M.

Willett W.C.

Rimm E.B.

Hu F.B. Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults. Am. J. Clin. Nutr. 104 : 1209-1217 View in Article Scopus (64)

PubMed

Crossref

Google Scholar

Moore T.J.

Vollmer W.M.

Appel L.J.

Sacks F.M.

Svetkey L.P.

Vogt T.M.

Conlin P.R.

Simons-Morton D.G.

Carter-Edwards L.

Harsha D.W. Effect of dietary patterns on ambulatory blood pressure : results from the dietary approaches to stop hypertension (DASH) trial. DASH collaborative research group. Hypertension. 34 : 472-477 View in Article PubMed

Crossref

Google Scholar

Sofi F.

Macchi C.

Abbate R.

Gensini G.F.

Casini A. Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 17 : 2769-2782 View in Article Scopus (373)

PubMed

Crossref

Google Scholar

Grosso G.

Marventano S.

Yang J.

Micek A.

Pajak A.

Scalfi L.

Galvano F.

Kales S.N. A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: are individual components equal?. Crit. Rev. Food Sci. Nutr. 57 : 3218-3232 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

de Lorgeril M.

Salen P.

Martin J.L.

Monjaud I.

Delaye J.

Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 99 : 779-785 View in Article PubMed

Crossref

Google Scholar

Estruch R.

Ros E.

Salas-Salvadó J.

Covas M.I.

Corella D.

Arós F.

Gómez-Gracia E.

Ruiz-Gutiérrez V.

Fiol M.

Lapetra J.

Lamuela-Raventos R.M.

Serra-Majem L.

Pintó X.

Basora J.

Muñoz M.A.

Sorlí J.V.

Martínez J.A.

Martínez-González M.A. Retraction and republication: primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 378 : 2441-2442 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Poli A.

Barbagallo C.M.

Cicero A.F.G.

Corsini A.

Manzato E.

Trimarco B.

Bernini F.

Visioli F.

Bianchi A.

Canzone G.

Crescini C.

de Kreutzenberg S.

Ferrara N.

Gambacciani M.

Ghiselli A.

Lubrano C.

Marelli G.

Marrocco W.

Montemurro V.

Parretti D.

Pedretti R.

Perticone F.

Stella R.

Marangoni F. Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper. Pharmacol. Res. 134 : 51-60 View in Article Scopus (21)

PubMed

Crossref

Google Scholar

Li Y.

Jiang L.

Jia Z.

Xin W.

Yang S.

Yang Q.

Wang L. A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. PLoS One. 9 e98611 View in Article Scopus (62)

PubMed

Crossref

Google Scholar

Zomer E.

Gurusamy K.

Leach R.

Trimmer C.

Lobstein T.

Morris S.

James W.P.

Finer N. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes. Rev. 17 : 1001-1011 View in Article Scopus (39)

PubMed

Crossref

Google Scholar

Shaw K.

Gennat H.

O'Rourke P.

Del Mar C. Exercise for overweight or obesity. Cochrane Database Syst. Rev. 4 : CD003817 View in Article PubMed

Crossref

Google Scholar

Rimm E.B.

Williams P.

Fosher K.

Criqui M.

Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 319 : 1523-1528 View in Article PubMed

Crossref

Google Scholar

Kelishadi R.

Mansourian M.

Heidari-Beni M. Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis. Nutrition. 30 : 503-510 View in Article Scopus (82)

PubMed

Crossref

Google Scholar

Stanhope K.L.

Schwarz J.M.

Keim N.L.

Griffen S.C.

Bremer A.A.

Graham J.L.

Hatcher B.

Cox C.L.

Dyachenko A.

Zhang W.

McGahan J.P.

Seibert A.

Krauss R.M.

Chiu S.

Schaefer E.J.

Ai M.

Otokozawa S.

Nakajima K.

Nakano T.

Beysen C.

Hellerstein M.K.

Berglund L.

Havel P.J. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 119 : 1322-1334 View in Article Scopus (999)

PubMed

Crossref

Google Scholar

Mensink R.P.

Zock P.L.

Kester A.D.

Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77 : 1146-1155 View in Article PubMed

Crossref

Google Scholar

Huffman K.M.

Hawk V.H.

Henes S.T.

Ocampo C.I.

Orenduff M.C.

Slentz C.A.

Johnson J.L.

Houmard J.A.

Samsa G.P.

Kraus W.E.

Bales C.W. Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in studies of a targeted risk reduction intervention through defined exercise I. Am. Heart J. 164 : 117-124 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Kraus W.E.

Houmard J.A.

Duscha B.D.

Knetzger K.J.

Wharton M.B.

McCartney J.S.

Bales C.W.

Henes S.

Samsa G.P.

Otvos J.D.

Kulkarni K.R.

Slentz C.A. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 347 : 1483-1492 View in Article Scopus (934)

PubMed

Crossref

Google Scholar

Brien S.E.

Ronksley P.E.

Turner B.J.

Mukamal K.J.

Ghali W.A. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 342 : d636 View in Article Scopus (411)

PubMed

Crossref

Google Scholar

De Natale C.

Annuzzi G.

Bozzetto L.

Mazzarella R.

Costabile G.

Ciano O.

Riccardi G.

Rivellese A.A. Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care. 32 : 2168-2173 View in Article Scopus (68)

PubMed

Crossref

Google Scholar

Liu S.

Manson J.E.

Stampfer M.J.

Holmes M.D.

Hu F.B.

Hankinson S.E.

Willett W.C. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am. J. Clin. Nutr. 73 : 560-566 View in Article PubMed

Crossref

Google Scholar

Stanhope K.L.

Medici V.

Bremer A.A.

Lee V.

Lam H.D.

Nunez M.V.

Chen G.X.

Keim N.L.

Havel P.J. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. Am. J. Clin. Nutr. 101 : 1144-1154 View in Article Scopus (103)

PubMed

Crossref

Google Scholar

Taskinen M.R.

Soderlund S.

Bogl L.H.

Hakkarainen A.

Matikainen N.

Pietilainen K.H.

Rasanen S.

Lundbom N.

Bjornson E.

Eliasson B.

Mancina R.M.

Romeo S.

Almeras N.

Pepa G.D.

Vetrani C.

Prinster A.

Annuzzi G.

Rivellese A.

Despres J.P.

Boren J. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. J. Intern. Med. 282 : 187-201 View in Article Scopus (32)

PubMed

Crossref

Google Scholar

Look Ahead Research Group

Wing R.R.

Bolin P.

Brancati F.L.

Bray G.A.

Clark J.M.

Coday M.

Crow R.S.

Curtis J.M.

Egan C.M.

Espeland M.A.

Evans M.

Foreyt J.P.

Ghazarian S.

Gregg E.W.

Harrison B.

Hazuda H.P.

Hill J.O.

Horton E.S.

Hubbard V.S.

Jakicic J.M.

Jeffery R.W.

Johnson K.C.

Kahn S.E.

Kitabchi A.E.

Knowler W.C.

Lewis C.E.

Maschak-Carey B.J.

Montez M.G.

Murillo A.

Nathan D.M.

Patricio J.

Peters A.

Pi-Sunyer X.

Pownall H.

Reboussin D.

Regensteiner J.G.

Rickman A.D.

Ryan D.H.

Safford M.

Wadden T.A.

Wagenknecht L.E.

West D.S.

Williamson D.F.

Yanovski S.Z. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N. Engl. J. Med. 369 : 145-154 View in Article Scopus (1310)

PubMed

Crossref

Google Scholar

Batsis J.A.

Gill L.E.

Masutani R.K.

Adachi-Mejia A.M.

Blunt H.B.

Bagley P.J.

Lopez-Jimenez F.

Bartels S.J. Weight loss interventions in older adults with obesity: a systematic review of randomized controlled trials since 2005. J. Am. Geriatr. Soc. 65 : 257-268 View in Article Scopus (47)

PubMed

Crossref

Google Scholar

Harris W.S.

Mozaffarian D.

Rimm E.

Kris-Etherton P.

Rudel L.L.

Appel L.J.

Engler M.M.

Engler M.B.

Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American heart association nutrition subcommittee of the Council on nutrition, physical activity, and metabolism; Council on cardiovascular nursing; and Council on epidemiology and prevention. Circulation. 119 : 902-907 View in Article Scopus (487)

PubMed

Crossref

Google Scholar

Mozaffarian D.

Lemaitre R.N.

King I.B.

Song X.

Huang H.

Sacks F.M.

Rimm E.B.

Wang M.

Siscovick D.S. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann. Intern. Med. 158 : 515-525 View in Article Scopus (172)

PubMed

Crossref

Google Scholar

Dehghan M.

Mente A.

Rangarajan S.

Sheridan P.

Mohan V.

Iqbal R.

Gupta R.

Lear S.

Wentzel-Viljoen E.

Avezum A.

Lopez-Jaramillo P.

Mony P.

Varma R.P.

Kumar R.

Chifamba J.

Alhabib K.F.

Mohammadifard N.

Oguz A.

Lanas F.

Rozanska D.

Bostrom K.B.

Yusoff K.

Tsolkile L.P.

Dans A.

Yusufali A.

Orlandini A.

Poirier P.

Khatib R.

Hu B.

Wei L.

Yin L.

Deeraili A.

Yeates K.

Yusuf R.

Ismail N.

Mozaffarian D.

Teo K.

Anand S.S.

Yusuf S. Prospective Urban Rural Epidemiology study investigators. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 392 : 2288-2297 View in Article Scopus (0)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Wood A.M.

Kaptoge S.

Butterworth A.S.

Willeit P.

Warnakula S.

Bolton T.

Paige E.

Paul D.S.

Sweeting M.

Burgess S.

Bell S.

Astle W.

Stevens D.

Koulman A.

Selmer R.M.

Verschuren W.M.M.

Sato S.

Njolstad I.

Woodward M.

Salomaa V.

Nordestgaard B.G.

Yeap B.B.

Fletcher A.

Melander O.

Kuller L.H.

Balkau B.

Marmot M.

Koenig W.

Casiglia E.

Cooper C.

Arndt V.

Franco O.H.

Wennberg P.

Gallacher J.

de la Camara A.G.

Volzke H.

Dahm C.C.

Dale C.E.

Bergmann M.M.

Crespo C.J.

van der Schouw Y.T.

Kaaks R.

Simons L.A.

Lagiou P.

Schoufour J.D.

Boer J.M.A.

Key T.J.

Rodriguez B.

Moreno-Iribas C.

Davidson K.W.

Taylor J.O.

Sacerdote C.

Wallace R.B.

Quiros J.R.

Tumino R.

Blazer II, D.G.

Linneberg A.

Daimon M.

Panico S.

Howard B.

Skeie G.

Strandberg T.

Weiderpass E.

Nietert P.J.

Psaty B.M.

Kromhout D.

Salamanca-Fernandez E.

Kiechl S.

Krumholz H.M.

Grioni S.

Palli D.

Huerta J.M.

Price J.

Sundstrom J.

Arriola L.

Arima H.

Travis R.C.

Panagiotakos D.B.

Karakatsani A.

Trichopoulou A.

Kuhn T.

Grobbee D.E.

Barrett-Connor E.

van Schoor N.

Boeing H.

Overvad K.

Kauhanen J.

Wareham N.

Langenberg C.

Forouhi N.

Wennberg M.

Despres J.P.

Cushman M.

Cooper J.A.

Rodriguez C.J.

Sakurai M.

Shaw J.E.

Knuiman M.

Voortman T.

Meisinger C.

Tjonneland A.

Brenner H.

Palmieri L.

Dallongeville J.

Brunner E.J.

Assmann G.

Trevisan M.

Gillum R.F.

Ford I.

Sattar N.

Lazo M.

Thompson S.G.

Ferrari P.

Leon D.A.

Smith G.D.

Peto R.

Jackson R.

Banks E.

Di Angelantonio E.

Danesh J. Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 391 : 1513-1523 View in Article Scopus (0)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Hartley L.

May M.D.

Loveman E.

Colquitt J.L.

Rees K. Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 1 : CD011472 View in Article Google Scholar

Pirro M.

Vetrani C.

Bianchi C.

Mannarino M.R.

Bernini F.

Rivellese A.A. Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian society of diabetology (SID) and of the Italian society for the study of arteriosclerosis (SISA). Nutr. Metab. Cardiovasc. Dis. 27 : 2-17 View in Article PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Dewell A.

Hollenbeck P.L.

Hollenbeck C.B. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J. Clin. Endocrinol. Metab. 91 : 772-780 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Mas R.

Castano G.

Illnait J.

Fernandez L.

Fernandez J.

Aleman C.

Pontigas V.

Lescay M. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin. Pharmacol. Ther. 65 : 439-447 View in Article PubMed

Crossref

Google Scholar

Lan J.

Zhao Y.

Dong F.

Yan Z.

Zheng W.

Fan J.

Sun G. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J. Ethnopharmacol. 161 : 69-81 View in Article Scopus (142)

PubMed

Crossref

Google Scholar

Sacks F.M.

Lichtenstein A.H.

Wu J.H.Y.

Appel L.J.

Creager M.A.

Kris-Etherton P.M.

Miller M.

Rimm E.B.

Rudel L.L.

Robinson J.G.

Stone N.J.

Van Horn L.V. American Heart Association. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 136 : e1-e23 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Bhatt D.L.

Steg P.G.

Miller M.

Brinton E.A.

Jacobson T.A.

Ketchum S.B.

Doyle Jr., R.T.

Juliano R.A.

Jiao L.

Granowitz C.

Tardif J.C.

Ballantyne C.M.

REDUCE-IT Investigators Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N. Engl. J. Med. 380 : 11-22 View in Article Scopus (356)

PubMed

Crossref

Google Scholar

Chasman D.I.

Giulianini F.

MacFadyen J.

Barratt B.J.

Nyberg F.

Ridker P.M. Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) trial. Circ Cardiovasc Genet. 5 : 257-264 View in Article Scopus (171)

PubMed

Crossref

Google Scholar

Stroes E.

Colquhoun D.

Sullivan D.

Civeira F.

Rosenson R.S.

Watts G.F.

Bruckert E.

Cho L.

Dent R.

Knusel B.

Xue A.

Scott R.

Wasserman S.M.

Rocco M.

GAUSS-2 Investigators Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab. J. Am. Coll. Cardiol. 63 : 2541-2548 View in Article Scopus (365)

PubMed

Crossref

Google Scholar

Sharma A.

Joshi P.H.

Rinehart S.

Thakker K.M.

Lele A.

Voros S. Baseline very low-density lipoprotein cholesterol is associated with the magnitude of triglyceride lowering on statins, fenofibric acid, or their combination in patients with mixed dyslipidemia. J Cardiovasc Transl Res. 7 : 465-474 View in Article Scopus (6)

PubMed

Crossref

Google Scholar

Barter P.J.

Brandrup-Wognsen G.

Palmer M.K.

Nicholls S.J. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. J. Lipid Res. 51 : 1546-1553 View in Article Scopus (140)

PubMed

Crossref

Google Scholar

Tsimikas S.

Witztum J.L.

Miller E.R.

Sasiela W.J.

Szarek M.

Olsson A.G.

Schwartz G.G. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation. 110 : 1406-1412 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Khera A.V.

Everett B.M.

Caulfield M.P.

Hantash F.M.

Wohlgemuth J.

Ridker P.M.

Mora S. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Circulation. 129 : 635-642 View in Article Scopus (173)

PubMed

Crossref

Google Scholar

Gould A.L.

Rossouw J.E.

Santanello N.C.

Heyse J.F.

Furberg C.D. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation. 91 : 2274-2282 View in Article PubMed

Crossref

Google Scholar

Gould A.L.

Rossouw J.E.

Santanello N.C.

Heyse J.F.

Furberg C.D. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation. 97 : 946-952 View in Article PubMed

Crossref

Google Scholar

LaRosa J.C.

He J.

Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. J. Am. Med. Assoc. 282 : 2340-2346 View in Article PubMed

Crossref

Google Scholar

Mills E.J.

Wu P.

Chong G.

Ghement I.

Singh S.

Akl E.A.

Eyawo O.

Guyatt G.

Berwanger O.

Briel M. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 104 : 109-124 View in Article Scopus (225)

PubMed

Crossref

Google Scholar

Ray K.K.

Seshasai S.R.

Erqou S.

Sever P.

Jukema J.W.

Ford I.

Sattar N. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch. Intern. Med. 170 : 1024-1031 View in Article Scopus (354)

PubMed

Crossref

Google Scholar

Taylor F.

Huffman M.D.

Macedo A.F.

Moore T.H.

Burke M.

Davey Smith G.

Ward K.

Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 1 : CD004816 View in Article PubMed

Crossref

Google Scholar

Cholesterol Treatment Trialists Collaboration

Herrington W.G.

Emberson J.

Mihaylova B.

Blackwell L.

Reith C.

Solbu M.D.

Mark P.B.

Fellstrom B.

Jardine A.G.

Wanner C.

Holdaas H.

Fulcher J.

Haynes R.

Landray M.J.

Keech A.

Simes J.

Collins R.

Baigent C. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes Endocrinol. 4 : 829-839 View in Article Scopus (65)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Naci H.

Brugts J.J.

Fleurence R.

Tsoi B.

Toor H.

Ades A.E. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol. 20 : 641-657 View in Article Scopus (117)

PubMed

Crossref

Google Scholar

Ford I.

Murray H.

McCowan C.

Packard C.J. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study. Circulation. 133 : 1073-1080 View in Article Scopus (110)

PubMed

Crossref

Google Scholar

Rogers J.K.

Jhund P.S.

Perez A.C.

Bohm M.

Cleland J.G.

Gullestad L.

Kjekshus J.

van Veldhuisen D.J.

Wikstrand J.

Wedel H.

McMurray J.J.

Pocock S.J. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA trial (controlled rosuvastatin multinational trial in heart failure). JACC Heart Fail. 2 : 289-297 View in Article Scopus (68)

PubMed

Crossref

Google Scholar

Wanner C.

Krane V.

Marz W.

Olschewski M.

Mann J.F.

Ruf G.

Ritz E. German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353 : 238-248 View in Article Scopus (1919)

PubMed

Crossref

Google Scholar

Fellström B.C.

Jardine A.G.

Schmieder R.E.

Holdaas H.

Bannister K.

Beutler J.

Chae D.W.

Chevaile A.

Cobbe S.M.

Gronhagen-Riska C.

De Lima J.J.

Lins R.

Mayer G.

McMahon A.W.

Parving H.H.

Remuzzi G.

Samuelsson O.

Sonkodi S.

Sci D.

Süleymanlar G.

Tsakiris D.

Tesar V.

Todorov V.

Wiecek A.

Wüthrich R.P.

Gottlow M.

Johnsson E.

Zannad F.

AURORA Study Group Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360 : 1395-1407 View in Article Scopus (1342)

PubMed

Crossref

Google Scholar

Baigent C.

Landray M.J.

Reith C.

Emberson J.

Wheeler D.C.

Tomson C.

Wanner C.

Krane V.

Cass A.

Craig J.

Neal B.

Jiang L.

Hooi L.S.

Levin A.

Agodoa L.

Gaziano M.

Kasiske B.

Walker R.

Massy Z.A.

Feldt-Rasmussen B.

Krairittichai U.

Ophascharoensuk V.

Fellstrom B.

Holdaas H.

Tesar V.

Wiecek A.

Grobbee D.

de Zeeuw D.

Gronhagen-Riska C.

Dasgupta T.

Lewis D.

Herrington W.

Mafham M.

Majoni W.

Wallendszus K.

Grimm R.

Pedersen T.

Tobert J.

Armitage J.

Baxter A.

Bray C.

Chen Y.

Chen Z.

Hill M.

Knott C.

Parish S.

Simpson D.

Sleight P.

Young A.

Collins R.

SHARP Investigators The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 377 : 2181-2192 View in Article Scopus (1524)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Cholesterol Treatment Trialists Collaboration

Emberson J.R.

Kearney P.M.

Blackwell L.

Newman C.

Reith C.

Bhala N.

Holland L.

Peto R.

Keech A.

Collins R.

Simes J.

Baigent C. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One. 7 e29849 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

McGuinness B.

Craig D.

Bullock R.

Malouf R.

Passmore P. Statins for the treatment of dementia. Cochrane Database Syst. Rev. 7 : CD007514 View in Article PubMed

Google Scholar

Eslami L.

Merat S.

Malekzadeh R.

Nasseri-Moghaddam S.

Aramin H. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Cochrane Database Syst. Rev. 12 : CD008623 View in Article PubMed

Google Scholar

Rahimi K.

Bhala N.

Kamphuisen P.

Emberson J.

Biere-Rafi S.

Krane V.

Robertson M.

Wikstrand J.

McMurray J. Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Med. 9 ( ) e1001310 https://doi.org/10.1371/journal.pmed.1001310 View in Article Scopus (63)

PubMed

Crossref

Google Scholar

Rahimi K.

Emberson J.

McGale P.

Majoni W.

Merhi A.

Asselbergs F.W.

Krane V.

Macfarlane P.W.

PROSPER Executive Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ. 342 : d1250 View in Article Scopus (90)

PubMed

Crossref

Google Scholar

Raval A.D.

Hunter T.

Stuckey B.

Hart R.J. Statins for women with polycystic ovary syndrome not actively trying to conceive. Cochrane Database Syst. Rev. 10 : CD008565 View in Article Google Scholar

McGuinness B.

Craig D.

Bullock R.

Passmore P. Statins for the prevention of dementia. Cochrane Database Syst. Rev. 1 : CD003160 View in Article Google Scholar

Giugliano R.P.

Mach F.

Zavitz K.

Kurtz C.

Im K.

Kanevsky E.

Schneider J.

Wang H.

Keech A.

Pedersen T.R.

Sabatine M.S.

Sever P.S.

Robinson J.G.

Honarpour N.

Wasserman S.M.

Ott B.R.

EBBINGHAUS Investigators Cognitive function in a randomized trial of evolocumab. N. Engl. J. Med. 377 : 633-643 View in Article Scopus (78)

PubMed

Crossref

Google Scholar

Mach F.

Ray K.K.

Wiklund O.

Corsini A.

Catapano A.L.

Bruckert E.

De Backer G.

Hegele R.A.

Hovingh G.K.

Jacobson T.A.

Krauss R.M.

Laufs U.

Leiter L.A.

Marz W.

Nordestgaard B.G.

Raal F.J.

Roden M.

Santos R.D.

Stein E.A.

Stroes E.S.

Thompson P.D.

Tokgozoglu L.

Vladutiu G.D.

Gencer B.

Stock J.K.

Ginsberg H.N.

Chapman M.J. European Atherosclerosis Society Consensus Panel. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur. Heart J. 39 : 2526-2539 View in Article PubMed

Crossref

Google Scholar

Collins R.

Reith C.

Emberson J.

Armitage J.

Baigent C.

Blackwell L.

Blumenthal R.

Danesh J.

Smith G.D.

DeMets D.

Evans S.

Law M.

MacMahon S.

Martin S.

Neal B.

Poulter N.

Preiss D.

Ridker P.

Roberts I.

Rodgers A.

Sandercock P.

Schulz K.

Sever P.

Simes J.

Smeeth L.

Wald N.

Yusuf S.

Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 388 : 2532-2561 View in Article PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Stroes E.S.

Thompson P.D.

Corsini A.

Vladutiu G.D.

Raal F.J.

Ray K.K.

Roden M.

Stein E.

Tokgozoglu L.

Nordestgaard B.G.

Bruckert E.

De Backer G.

Krauss R.M.

Laufs U.

Santos R.D.

Hegele R.A.

Hovingh G.K.

Leiter L.A.

Mach F.

Marz W.

Newman C.B.

Wiklund O.

Jacobson T.A.

Catapano A.L.

Chapman M.J.

Ginsberg H.N. European atherosclerosis society consensus panel. Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management. Eur. Heart J. 36 : 1012-1022 View in Article Scopus (584)

PubMed

Crossref

Google Scholar

Bruckert E.

Hayem G.

Dejager S.

Yau C.

Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc. Drugs Ther. 19 : 403-414 View in Article Scopus (814)

PubMed

Crossref

Google Scholar

Finegold J.A.

Manisty C.H.

Goldacre B.

Barron A.J.

Francis D.P. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur J Prev Cardiol. 21 : 464-474 View in Article Scopus (122)

PubMed

Crossref

Google Scholar

Naci H.

Brugts J.

Ades T. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials. Circ Cardiovasc Qual Outcomes. 6 : 390-399 View in Article Scopus (179)

PubMed

Crossref

Google Scholar

Sattar N.

Preiss D.

Murray H.M.

Welsh P.

Buckley B.M.

de Craen A.J.

Seshasai S.R.

McMurray J.J.

Freeman D.J.

Jukema J.W.

Macfarlane P.W.

Packard C.J.

Stott D.J.

Westendorp R.G.

Shepherd J.

Davis B.R.

Pressel S.L.

Marchioli R.

Marfisi R.M.

Maggioni A.P.

Tavazzi L.

Tognoni G.

Kjekshus J.

Pedersen T.R.

Cook T.J.

Gotto A.M.

Clearfield M.B.

Downs J.R.

Nakamura H.

Ohashi Y.

Mizuno K.

Ray K.K.

Ford I. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 375 : 735-742 View in Article Scopus (1556)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Preiss D.

Seshasai S.R.

Welsh P.

Murphy S.A.

Ho J.E.

Waters D.D.

DeMicco D.A.

Barter P.

Cannon C.P.

Sabatine M.S.

Braunwald E.

Kastelein J.J.

de Lemos J.A.

Blazing M.A.

Pedersen T.R.

Tikkanen M.J.

Sattar N.

Ray K.K. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. J. Am. Med. Assoc. 305 : 2556-2564 View in Article Scopus (790)

PubMed

Crossref

Google Scholar

Waters D.D.

Ho J.E.

Boekholdt S.M.

DeMicco D.A.

Kastelein J.J.

Messig M.

Breazna A.

Pedersen T.R. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes. J. Am. Coll. Cardiol. 61 : 148-152 View in Article Scopus (121)

PubMed

Crossref

Google Scholar

Swerdlow D.I.

Preiss D.

Kuchenbaecker K.B.

Holmes M.V.

Engmann J.E.

Shah T.

Sofat R.

Stender S.

Johnson P.C.

Scott R.A.

Leusink M.

Verweij N.

Sharp S.J.

Guo Y.

Giambartolomei C.

Chung C.

Peasey A.

Amuzu A.

Li K.

Palmen J.

Howard P.

Cooper J.A.

Drenos F.

Li Y.R.

Lowe G.

Gallacher J.

Stewart M.C.

Tzoulaki I.

Buxbaum S.G.

van der A.D.

Forouhi N.G.

Onland-Moret N.C.

van der Schouw Y.T.

Schnabel R.B.

Hubacek J.A.

Kubinova R

Baceviciene M.

Tamosiunas A.

Pajak A.

Topor-Madry R.

Stepaniak U.

Malyutina S.

Baldassarre D.

Sennblad B.

Tremoli E.

de Faire U.

Veglia F.

Ford I.

Jukema J.W.

Westendorp R.G.

de Borst G.J.

de Jong P.A.

Algra A.

Spiering W.

Maitland-van der Zee A.H.

Klungel O.H.

de Boer A.

Doevendans P.A.

Eaton C.B.

Robinson J.G.

Duggan D.

Consortium D.

Consortium M.

InterAct C.

Kjekshus J.

Downs J.R.

Gotto A.M.

Keech A.C.

Marchioli R.

Tognoni G.

Sever P.S.

Poulter N.R.

Waters D.D.

Pedersen T.R.

Amarenco P.

Nakamura H.

McMurray J.J.

Lewsey J.D.

Chasman D.I.

Ridker P.M.

Maggioni A.P.

Tavazzi L.

Ray K.K.

Seshasai S.R.

Manson J.E.

Price J.F.

Whincup P.H.

Morris R.W.

Lawlor D.A.

Smith G.D.

Ben-Shlomo Y.

Schreiner P.J.

Fornage M.

Siscovick D.S.

Cushman M.

Kumari M.

Wareham N.J.

Verschuren W.M.

Redline S.

Patel S.R.

Whittaker J.C.

Hamsten A.

Delaney J.A.

Dale C.

Gaunt T.R.

Wong A.

Kuh D.

Hardy R.

Kathiresan S.

Castillo B.A.

van der Harst P.

Brunner E.J.

Tybjaerg-Hansen A.

Marmot M.G.

Krauss R.M.

Tsai M.

Coresh J.

Hoogeveen R.C.

Psaty B.M.

Lange L.A.

Hakonarson H.

Dudbridge F.

Humphries S.E.

Talmud P.J.

Kivimaki M.

Timpson N.J.

Langenberg C.

Asselbergs F.W.

Voevoda M.

Bobak M.

Pikhart H.

Wilson J.G.

Reiner A.P.

Keating B.J.

Hingorani A.D.

Sattar N. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 385 : 351-361 View in Article Scopus (317)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Hackam D.G.

Woodward M.

Newby L.K.

Bhatt D.L.

Shao M.

Smith E.E.

Donner A.

Mamdani M.

Douketis J.D.

Arima H.

Chalmers J.

MacMahon S.

Tirschwell D.L.

Psaty B.M.

Bushnell C.D.

Aguilar M.I.

Capampangan D.J.

Werring D.J.

De Rango P.

Viswanathan A.

Danchin N.

Cheng C.L.

Yang Y.H.

Verdel B.M.

Lai M.S.

Kennedy J.

Uchiyama S.

Yamaguchi T.

Ikeda Y.

Mrkobrada M. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation. 124 : 2233-2242 View in Article Scopus (104)

PubMed

Crossref

Google Scholar

Palmer S.C.

Navaneethan S.D.

Craig J.C.

Perkovic V.

Johnson D.W.

Nigwekar S.U.

Hegbrant J.

Strippoli G.F. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst. Rev. 1 : CD005019 View in Article Google Scholar

Phan B.A.

Dayspring T.D.

Toth P.P. Ezetimibe therapy: mechanism of action and clinical update. Vasc. Health Risk Manag. 8 : 415-427 View in Article PubMed

Google Scholar

Pandor A.

Ara R.M.

Tumur I.

Wilkinson A.J.

Paisley S.

Duenas A.

Durrington P.N.

Chilcott J. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials. J. Intern. Med. 265 : 568-580 View in Article Scopus (97)

PubMed

Crossref

Google Scholar

Nissen S.E.

Stroes E.

Dent-Acosta R.E.

Rosenson R.S.

Lehman S.J.

Sattar N.

Preiss D.

Bruckert E.

Ceska R.

Lepor N.

Ballantyne C.M.

Gouni-Berthold I.

Elliott M.

Brennan D.M.

Wasserman S.M.

Somaratne R.

Scott R.

Stein E.A.

Gauss-3 Investigators Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial. J. Am. Med. Assoc. 315 : 1580-1590 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Rossebø A.B.

Pedersen T.R.

Boman K.

Brudi P.

Chambers J.B.

Egstrup K.

Gerdts E.

Gohlke-Bärwolf C.

Holme I.

Kesäniemi Y.A.

Malbecq W.

Nienaber C.A.

Ray S.

Skjaerpe T.

Wachtell K.

Willenheimer R. SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N. Engl. J. Med. 359 : 1343-1356 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Sharp Collaborative Group Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am. Heart J. 160 ( ) : 785-794 View in Article Scopus (194)

PubMed

Crossref

Google Scholar

Ference B.A.

Cannon C.P.

Landmesser U.

Luscher T.F.

Catapano A.L.

Ray K.K. Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur. Heart J. 39 : 2540-2545 View in Article PubMed

Crossref

Google Scholar

Myocardial Infarction Genetics Consortium Investigators

Stitziel N.O.

Won H.H.

Morrison A.C.

Peloso G.M.

Do R.

Lange L.A.

Fontanillas P.

Gupta N.

Duga S.

Goel A.

Farrall M.

Saleheen D.

Ferrario P.

Konig I.

Asselta R.

Merlini P.A.

Marziliano N.

Notarangelo M.F.

Schick U.

Auer P.

Assimes T.L.

Reilly M.

Wilensky R.

Rader D.J.

Hovingh G.K.

Meitinger T.

Kessler T.

Kastrati A.

Laugwitz K.L.

Siscovick D.

Rotter J.I.

Hazen S.L.

Tracy R.

Cresci S.

Spertus J.

Jackson R.

Schwartz S.M.

Natarajan P.

Crosby J.

Muzny D.

Ballantyne C.

Rich S.S.

O'Donnell C.J.

Abecasis G.

Sunyaev S.

Nickerson D.A.

Buring J.E.

Ridker P.M.

Chasman D.I.

Austin E.

Ye Z.

Kullo I.J.

Weeke P.E.

Shaffer C.M.

Bastarache L.A.

Denny J.C.

Roden D.M.

Palmer C.

Deloukas P.

Lin D.Y.

Tang Z.Z.

Erdmann J.

Schunkert H.

Danesh J.

Marrugat J.

Elosua R.

Ardissino D.

McPherson R.

Watkins H.

Reiner A.P.

Wilson J.G.

Altshuler D.

Gibbs R.A.

Lander E.S.

Boerwinkle E.

Gabriel S.

Kathiresan S. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371 : 2072-2082 View in Article Scopus (254)

PubMed

Crossref

Google Scholar

Tsujita K.

Sugiyama S.

Sumida H.

Shimomura H.

Yamashita T.

Yamanaga K.

Komura N.

Sakamoto K.

Oka H.

Nakao K.

Nakamura S.

Ishihara M.

Matsui K.

Sakaino N.

Nakamura N.

Yamamoto N.

Koide S.

Matsumura T.

Fujimoto K.

Tsunoda R.

Morikami Y.

Matsuyama K.

Oshima S.

Kaikita K.

Hokimoto S.

Ogawa H. PRECISE-IVUS Investigators. Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial. J. Am. Coll. Cardiol. 66 : 495-507 View in Article PubMed

Crossref

Google Scholar

Khan S.U.

Talluri S.

Riaz H.

Rahman H.

Nasir F.

Bin Riaz I.

Sattur S.

Ahmed H.

Kaluski E.

Krasuski R. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes. Eur J Prev Cardiol. 25 : 844-853 View in Article Scopus (11)

PubMed

Crossref

Google Scholar

Koskinas K.C.

Siontis G.C.M.

Piccolo R.

Mavridis D.

Raber L.

Mach F.

Windecker S. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials. Eur. Heart J. 39 : 1172-1180 View in Article Scopus (39)

PubMed

Crossref

Google Scholar

The Lipid Research Clinics Program The lipid research clinics coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease. J. Am. Med. Assoc. 251 : 351-364 View in Article Scopus (3188)

Crossref

Google Scholar

The Lipid Research Clinics Program The lipid research clinics coronary primary prevention trial. Results of 6 years of post-trial follow-up. The lipid research clinics investigators. Arch. Intern. Med. 152 : 1399-1410 View in Article Scopus (60)

PubMed

Crossref

Google Scholar

Abifadel M.

Varret M.

Rabes J.P.

Allard D.

Ouguerram K.

Devillers M.

Cruaud C.

Benjannet S.

Wickham L.

Erlich D.

Derre A.

Villeger L.

Farnier M.

Beucler I.

Bruckert E.

Chambaz J.

Chanu B.

Lecerf J.M.

Luc G.

Moulin P.

Weissenbach J.

Prat A.

Krempf M.

Junien C.

Seidah N.G.

Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34 : 154-156 View in Article Scopus (1693)

PubMed

Crossref

Google Scholar

Cho L.

Rocco M.

Colquhoun D.

Sullivan D.

Rosenson R.S.

Dent R.

Xue A.

Scott R.

Wasserman S.M.

Stroes E. Clinical profile of statin intolerance in the phase 3 GAUSS-2 Study. Cardiovasc. Drugs Ther. 30 : 297-304 View in Article PubMed

Crossref

Google Scholar

Schmidt A.F.

Pearce L.S.

Wilkins J.T.

Overington J.P.

Hingorani A.D.

Casas J.P. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 4 : CD011748 View in Article PubMed

Google Scholar

Thedrez A.

Blom D.J.

Ramin-Mangata S.

Blanchard V.

Croyal M.

Chemello K.

Nativel B.

Pichelin M.

Cariou B.

Bourane S.

Tang L.

Farnier M.

Raal F.J.

Lambert G. Homozygous familial hypercholesterolemia patients with identical mutations variably express the LDLR (low-density lipoprotein receptor): implications for the efficacy of evolocumab. Arterioscler. Thromb. Vasc. Biol. 38 : 592-598 View in Article PubMed

Crossref

Google Scholar

Robinson J.G.

Farnier M.

Krempf M.

Bergeron J.

Luc G.

Averna M.

Stroes E.S.

Langslet G.

Raal F.J.

El Shahawy M.

Koren M.J.

Lepor N.E.

Lorenzato C.

Pordy R.

Chaudhari U.

Kastelein J.J.

ODYSSEY LONG TERM Investigators Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N. Engl. J. Med. 372 : 1489-1499 View in Article Scopus (1157)

PubMed

Crossref

Google Scholar

Gaudet D.

Kereiakes D.J.

McKenney J.M.

Roth E.M.

Hanotin C.

Gipe D.

Du Y.

Ferrand A.C.

Ginsberg H.N.

Stein E.A. Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials). Am. J. Cardiol. 114 : 711-715 View in Article PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Raal F.J.

Giugliano R.P.

Sabatine M.S.

Koren M.J.

Langslet G.

Bays H.

Blom D.

Eriksson M.

Dent R.

Wasserman S.M.

Huang F.

Xue A.

Albizem M.

Scott R.

Stein E.A. Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials. J. Am. Coll. Cardiol. 63 : 1278-1288 View in Article Scopus (228)

PubMed

Crossref

Google Scholar

Sabatine M.S.

Giugliano R.P.

Wiviott S.D.

Raal F.J.

Blom D.J.

Robinson J.

Ballantyne C.M.

Somaratne R.

Legg J.

Wasserman S.M.

Scott R.

Koren M.J.

Stein E.A. Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N. Engl. J. Med. 372 : 1500-1509 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Navarese E.P.

Kolodziejczak M.

Kereiakes D.J.

Tantry U.S.

O'Connor C.

Gurbel P.A. Proprotein convertase subtilisin/kexin type 9 monoclonal antibodies for acute coronary syndrome: a narrative review. Ann. Intern. Med. 164 : 600-607 View in Article PubMed

Crossref

Google Scholar

Lipinski M.J.

Benedetto U.

Escarcega R.O.

Biondi-Zoccai G.

Lhermusier T.

Baker N.C.

Torguson R.

Brewer Jr., H.B.

Waksman R. The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis. Eur. Heart J. 37 : 536-545 View in Article PubMed

Crossref

Google Scholar

Schmidt A.F.

Swerdlow D.I.

Holmes M.V.

Patel R.S.

Fairhurst-Hunter Z.

Lyall D.M.

Hartwig F.P.

Horta B.L.

Hypponen E.

Power C.

Moldovan M.

van Iperen E.

Hovingh G.K.

Demuth I.

Norman K.

Steinhagen-Thiessen E.

Demuth J.

Bertram L.

Liu T.

Coassin S.

Willeit J.

Kiechl S.

Willeit K.

Mason D.

Wright J.

Morris R.

Wanamethee G.

Whincup P.

Ben-Shlomo Y.

McLachlan S.

Price J.F.

Kivimaki M.

Welch C.

Sanchez-Galvez A.

Marques-Vidal P.

Nicolaides A.

Panayiotou A.G.

Onland-Moret N.C.

van der Schouw Y.T.

Matullo G.

Fiorito G.

Guarrera S.

Sacerdote C.

Wareham N.J.

Langenberg C.

Scott R.

Luan J.

Bobak M.

Malyutina S.

Pajak A.

Kubinova R.

Tamosiunas A.

Pikhart H.

Husemoen L.L.

Grarup N.

Pedersen O.

Hansen T.

Linneberg A.

Simonsen K.S.

Cooper J.

Humphries S.E.

Brilliant M.

Kitchner T.

Hakonarson H.

Carrell D.S.

McCarty C.A.

Kirchner H.L.

Larson E.B.

Crosslin D.R.

de Andrade M.

Roden D.M.

Denny J.C.

Carty C.

Hancock S.

Attia J.

Holliday E.

O'Donnell M.

Yusuf S.

Chong M.

Pare G.

van der Harst P.

Said M.A.

Eppinga R.N.

Verweij N.

Snieder H.

LifeLines Cohort study g

Christen T.

Mook-Kanamori D.O.

Gustafsson S.

Lind L.

Ingelsson E.

Pazoki R.

Franco O.

Hofman A.

Uitterlinden A.

Dehghan A.

Teumer A.

Baumeister S.

Dorr M.

Lerch M.M.

Volker U.

Volzke H.

Ward J.

Pell J.P.

Smith D.J.

Meade T.

Maitland-van der Zee A.H.

Baranova E.V.

Young R.

Ford I.

Campbell A.

Padmanabhan S.

Bots M.L.

Grobbee D.E.

Froguel P.

Thuillier D.

Balkau B.

Bonnefond A.

Cariou B.

Smart M.

Bao Y.

Kumari M.

Mahajan A.

Ridker P.M.

Chasman D.I.

Reiner A.P.

Lange L.A.

Ritchie M.D.

Asselbergs F.W.

Casas J.P.

Keating B.J.

Preiss D.

Hingorani ADUCLEB consortiumSattar N PCSK9 genetic variants and risk of type 2 diabetes: a Mendelian randomisation study. Lancet Diabetes Endocrinol. 5 : 97-105 View in Article Scopus (135)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Cao Y.X.

Liu H.H.

Dong Q.T.

Li S.

Li J.J. Effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies on new-onset diabetes mellitus and glucose metabolism: a systematic review and meta-analysis. Diabetes Obes. Metab. 20 : 1391-1398 View in Article Scopus (19)

PubMed

Crossref

Google Scholar

de Carvalho L.S.F.

Campos A.M.

Sposito A.C. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes: a systematic review and meta-analysis with over 96,000 patient-years. Diabetes Care. 41 : 364-367 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Sabatine M.S.

Leiter L.A.

Wiviott S.D.

Giugliano R.P.

Deedwania P.

De Ferrari G.M.

Murphy S.A.

Kuder J.F.

Gouni-Berthold I.

Lewis B.S.

Handelsman Y.

Pineda A.L.

Honarpour N.

Keech A.C.

Sever P.S.

Pedersen T.R. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Lancet Diabetes Endocrinol. 5 : 941-950 View in Article Scopus (181)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Zhang X.L.

Zhu L.

Wei Z.H.

Zhu Q.Q.

Qiao J.Z.

Dai Q.

Huang W.

Li X.H.

Xie J.

Kang L.N.

Wang L.

Xu B. Comparative efficacy and safety of everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stents: a systematic review and meta-analysis. Ann. Intern. Med. 164 : 752-763 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Giugliano R.P.

Cannon C.P.

Blazing M.A.

Nicolau J.C.

Corbalan R.

Spinar J.

Park J.G.

White J.A.

Bohula E.A.

Braunwald E. IMPROVE-IT (improved reduction of outcomes: Vytorin efficacy international trial) investigators. Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (improved reduction of outcomes: Vytorin efficacy international trial). Circulation. 137 : 1571-1582 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Ridker P.M.

Tardif J.C.

Amarenco P.

Duggan W.

Glynn R.J.

Jukema J.W.

Kastelein J.J.P.

Kim A.M.

Koenig W.

Nissen S.

Revkin J.

Rose L.M.

Santos R.D.

Schwartz P.F.

Shear C.L.

Yunis C.

Investigators S.P.I.R.E. Lipid-reduction variability and antidrug-antibody formation with bococizumab. N. Engl. J. Med. 376 : 1517-1526 View in Article Scopus (146)

PubMed

Crossref

Google Scholar

Cuchel M.

Meagher E.A.

du Toit Theron H.

Blom D.J.

Marais A.D.

Hegele R.A.

Averna M.R.

Sirtori C.R.

Shah P.K.

Gaudet D.

Stefanutti C.

Vigna G.B.

Du Plessis A.M.

Propert K.J.

Sasiela W.J.

Bloedon L.T.

Rader D.J. Phase 3 HoFH Lomitapide Study investigators. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet. 381 : 40-46 View in Article Scopus (429)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Cuchel M.

Bloedon L.T.

Szapary P.O.

Kolansky D.M.

Wolfe M.L.

Sarkis A.

Millar J.S.

Ikewaki K.

Siegelman E.S.

Gregg R.E.

Rader D.J. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 356 : 148-156 View in Article Scopus (409)

PubMed

Crossref

Google Scholar

Li N.

Li Q.

Tian X.Q.

Qian H.Y.

Yang Y.J. Mipomersen is a promising therapy in the management of hypercholesterolemia: a meta-analysis of randomized controlled trials. Am. J. Cardiovasc. Drugs. 14 : 367-376 View in Article Scopus (20)

PubMed

Crossref

Google Scholar

Accord Study Group

Ginsberg H.N.

Elam M.B.

Lovato L.C.

Crouse III, J.R.

Leiter L.A.

Linz P.

Friedewald W.T.

Buse J.B.

Gerstein H.C.

Probstfield J.

Grimm R.H.

Ismail-Beigi F.

Bigger J.T.

Goff Jr., D.C.

Cushman W.C.

Simons-Morton D.G.

Byington R.P. Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med. 362 : 1563-1574 View in Article Scopus (1841)

PubMed

Crossref

Google Scholar

Frick M.H.

Elo O.

Haapa K.

Heinonen O.P.

Heinsalmi P.

Helo P.

Huttunen J.K.

Kaitaniemi P.

Koskinen P.

Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 317 : 1237-1245 View in Article PubMed

Crossref

Google Scholar

Rubins H.B.

Robins S.J.

Collins D.

Fye C.L.

Anderson J.W.

Elam M.B.

Faas F.H.

Linares E.

Schaefer E.J.

Schectman G.

Wilt T.J.

Wittes J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N. Engl. J. Med. 341 : 410-418 View in Article Scopus (3021)

PubMed

Crossref

Google Scholar

Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and significance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel. Circulation. 86 : 839-848 View in Article PubMed

Crossref

Google Scholar

Meade T.

Zuhrie R.

Cook C.

Cooper J. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ. 325 : 1139 View in Article PubMed

Crossref

Google Scholar

Keene D.

Price C.

Shun-Shin M.J.

Francis D.P. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 349 : g4379 View in Article Scopus (231)

PubMed

Crossref

Google Scholar

Bruckert E.

Labreuche J.

Deplanque D.

Touboul P.J.

Amarenco P. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis. J. Cardiovasc. Pharmacol. 57 : 267-272 View in Article Scopus (82)

PubMed

Crossref

Google Scholar

Jun M.

Zhu B.

Tonelli M.

Jardine M.J.

Patel A.

Neal B.

Liyanage T.

Keech A.

Cass A.

Perkovic V. Effects of fibrates in kidney disease: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 60 : 2061-2071 View in Article Scopus (101)

PubMed

Crossref

Google Scholar

Pradhan A.D.

Paynter N.P.

Everett B.M.

Glynn R.J.

Amarenco P.

Elam M.

Ginsberg H.

Hiatt W.R.

Ishibashi S.

Koenig W.

Nordestgaard B.G.

Fruchart J.C.

Libby P.

Ridker P.M. Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study. Am. Heart J. 206 : 80-93 View in Article Scopus (41)

PubMed

Crossref

Google Scholar

Graham D.J.

Staffa J.A.

Shatin D.

Andrade S.E.

Schech S.D.

La Grenade L.

Gurwitz J.H.

Chan K.A.

Goodman M.J.

Platt R. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. J. Am. Med. Assoc. 292 : 2585-2590 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Preiss D.

Tikkanen M.J.

Welsh P.

Ford I.

Lovato L.C.

Elam M.B.

LaRosa J.C.

DeMicco D.A.

Colhoun H.M.

Goldenberg I.

Murphy M.J.

MacDonald T.M.

Pedersen T.R.

Keech A.C.

Ridker P.M.

Kjekshus J.

Sattar N.

McMurray J.J. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. J. Am. Med. Assoc. 308 : 804-811 View in Article PubMed

Crossref

Google Scholar

Taskinen M.R.

Sullivan D.R.

Ehnholm C.

Whiting M.

Zannino D.

Simes R.J.

Keech A.C.

Barter P.J. FIELD study investigators. Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. Arterioscler. Thromb. Vasc. Biol. 29 : 950-955 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Abdelhamid A.S.

Brown T.J.

Brainard J.S.

Biswas P.

Thorpe G.C.

Moore H.J.

Deane K.H.

AlAbdulghafoor F.K.

Summerbell C.D.

Worthington H.V.

Song F.

Hooper L. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 7 : CD003177 View in Article PubMed

Google Scholar

Ascend Study Collaborative Group

Bowman L.

Mafham M.

Wallendszus K.

Stevens W.

Buck G.

Barton J.

Murphy K.

Aung T.

Haynes R.

Cox J.

Murawska A.

Young A.

Lay M.

Chen F.

Sammons E.

Waters E.

Adler A.

Bodansky J.

Farmer A.

McPherson R.

Neil A.

Simpson D.

Peto R.

Baigent C.

Collins R.

Parish S.

Armitage J. Effects of n-3 fatty acid supplements in diabetes mellitus. N. Engl. J. Med. 379 : 1540-1550 View in Article Scopus (136)

PubMed

Crossref

Google Scholar

Hooper L.

Thompson R.L.

Harrison R.A.

Summerbell C.D.

Ness A.R.

Moore H.J.

Worthington H.V.

Durrington P.N.

Higgins J.P.

Capps N.E.

Riemersma R.A.

Ebrahim S.B.

Davey Smith G. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 332 : 752-760 View in Article Scopus (532)

PubMed

Crossref

Google Scholar

Marchioli R.

Barzi F.

Bomba E.

Chieffo C.

Di Gregorio D.

Di Mascio R.

Franzosi M.G.

Geraci E.

Levantesi G.

Maggioni A.P.

Mantini L.

Marfisi R.M.

Mastrogiuseppe G.

Mininni N.

Nicolosi G.L.

Santini M.

Schweiger C.

Tavazzi L.

Tognoni G.

Tucci C.

Valagussa F.

GISSI-Prevenzione Investigators Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 105 : 1897-1903 View in Article Scopus (1085)

PubMed

Crossref

Google Scholar

Nicholls S.J.

Lincoff A.M.

Bash D.

Ballantyne C.M.

Barter P.J.

Davidson M.H.

Kastelein J.J.P.

Koenig W.

McGuire D.K.

Mozaffarian D.

Pedersen T.R.

Ridker P.M.

Ray K.

Karlson B.W.

Lundstrom T.

Wolski K.

Nissen S.E. Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: rationale and design of the STRENGTH trial. Clin. Cardiol. 41 : 1281-1288 View in Article Scopus (58)

PubMed

Crossref

Google Scholar

Manson J.E.

Cook N.R.

Lee I.M.

Christen W.

Bassuk S.S.

Mora S.

Gibson H.

Albert C.M.

Gordon D.

Copeland T.

D'Agostino D.

Friedenberg G.

Ridge C.

Bubes V.

Giovannucci E.L.

Willett W.C.

Buring J.E.

VITAL Research Group Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N. Engl. J. Med. 380 : 23-32 View in Article Scopus (168)

PubMed

Crossref

Google Scholar

Brasky T.M.

Darke A.K.

Song X.

Tangen C.M.

Goodman P.J.

Thompson I.M.

Meyskens Jr., F.L.

Goodman G.E.

Minasian L.M.

Parnes H.L.

Klein E.A.

Kristal A.R. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J. Natl. Cancer Inst. 105 : 1132-1141 View in Article Scopus (186)

PubMed

Crossref

Google Scholar

Barter P.J.

Caulfield M.

Eriksson M.

Grundy S.M.

Kastelein J.J.

Komajda M.

Lopez-Sendon J.

Mosca L.

Tardif J.C.

Waters D.D.

Shear C.L.

Revkin J.H.

Buhr K.A.

Fisher M.R.

Tall A.R.

Brewer B.

ILLUMINATE Investigators Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357 : 2109-2122 View in Article Scopus (2284)

PubMed

Crossref

Google Scholar

Ference B.A.

Kastelein J.J.P.

Ginsberg H.N.

Chapman M.J.

Nicholls S.J.

Ray K.K.

Packard C.J.

Laufs U.

Brook R.D.

Oliver-Williams C.

Butterworth A.S.

Danesh J.

Smith G.D.

Catapano A.L.

Sabatine M.S. Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk. J. Am. Med. Assoc. 318 : 947-956 View in Article Scopus (14)

PubMed

Crossref

Google Scholar

Fitzgerald K.

White S.

Borodovsky A.

Bettencourt B.R.

Strahs A.

Clausen V.

Wijngaard P.

Horton J.D.

Taubel J.

Brooks A.

Fernando C.

Kauffman R.S.

Kall